Table 1 Comparison of baseline characteristics according to the statin starting time
Variables | Statin use | No use | P value* | ||
|---|---|---|---|---|---|
D1 | D2 | D ≥ 3 | |||
(N = 45) | (N = 70) | (N = 52) | (N = 170) | ||
Age, years, mean ± SD | 67.6 ± 11.6 | 69.5 ± 12.0 | 68.0 ± 12.5 | 69.6 ± 12.7 | 0.69 |
Male sex | 30 (66.7 %) | 36 (51.4 %) | 31 (59.6 %) | 91 (53.5 %) | 0.34 |
Time from onset to arrival, hours, mean ± SD | 1.4 ± 1.3 | 1.6 ± 1.3 s | 1.6 ± 1.4 | 1.5 ± 1.2 | 0.66 |
History of stroke | 12 (26.7 %) | 12 (17.1 %) | 6 (11.5 %) | 46 (27.1 %) | 0.07 |
Hypertension | 28 (62.2 %) | 42 (60.0 %) | 32 (61.5 %) | 95 (55.9 %) | 0.80 |
Diabetes mellitus | 10 (22.2 %) | 13 (18.6 %) | 9 (17.3 %) | 30 (17.6 %) | 0.91 |
Atrial fibrillation | 15 (33.3 %) | 37 (52.9 %) | 12 (23.1 %) | 54 (31.8 %) | 0.003 |
Premorbid statin use | 8 (17.8 %) | 10 (14.3 %) | 6 (11.5 %) | 15 (8.8 %) | 0.33 |
Baseline NIHSS score, median (IQR) | 15 (7–18) | 11 (6-20) | 12 (7.5–17) | 15 (9–20) | 0.14 |
Stroke subtype | 0.002 | ||||
LAA | 20 (44.4 %) | 27 (38.6 %) | 21 (40.4 %) | 42 (24.7 %) | |
CE | 13 (28.9 %) | 39 (55.7 %) | 22 (42.3 %) | 96 (56.5 %) | |
UD or OD | 12 (26.7 %) | 4 (5.7 %) | 9 (17.3 %) | 32 (18.8 %) | |
Recanalization modality | 0.007 | ||||
IV-only | 15 (33.3 %) | 28 (40.0 %) | 13 (25.0 %) | 30 (17.6 %) | |
IA-only | 15 (33.3 %) | 15 (21.4 %) | 20 (38.5 %) | 55 (32.4 %) | |
Combined treatment | 15 (33.3 %) | 27 (38.6 %) | 19 (36.5 %) | 85 (50.0 %) | |